Jordina Rovira

Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy

Jordina Rovira, Alexandra Valera, Luís Colomo et al. · Annals of Hematology · 2014 · 119 citations · Full text

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study

Alfredo Rivas‐Delgado, Ferran Nadeu, Anna Enjuanes et al. · Clinical Cancer Research · 2020 · 91 citations · Full text

Validation of the <scp>NCCN</scp>‐<scp>IPI</scp> for diffuse large B‐cell lymphoma (<scp>DLBCL</scp>): the addition of β₂‐microglobulin yields a more accurate <scp>GELTAMO</scp>‐<scp>IPI</scp>

Carlos Montalbán, Antonio Díaz‐López, Iván Dlouhy et al. · British Journal of Haematology · 2017 · 81 citations · Full text

Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era

Alfredo Rivas‐Delgado, Laura Magnano, Miriam Moreno‐Velázquez et al. · British Journal of Haematology · 2018 · 79 citations · Full text

<i>MYD88</i> L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome

Jordina Rovira, Kennosuke Karube, Alexandra Valera et al. · Clinical Cancer Research · 2016 · 70 citations